[89Zr]Zr-Df-ATG-101

N/A

Report date: 2025/11/25 17:15:05
NME

Base Information

Drug Name[89Zr]Zr-Df-ATG-101
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 bindersProgrammed death-ligand 1 binders
TargetsTumor necrosis factor receptor superfamily member 9Programmed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAntengene Biologics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAntengene Biologics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A